Coadministering Recommended Vaccines at 11-to-12-Year Visit Could Improve HPV Vaccination Rates

Although the Centers for Disease Control and Prevention recommends administration of tetanus–diphtheria–acellular pertussis (Tdap), human papillomavirus (HPV), and quadrivalent meningococcal (MenACWY) vaccines at age 11 to 12 years, HPV vaccination rates lag behind those of the other two.

Investigators used data from a large U.S. commercial medical claims database to study vaccination patterns among more than 1.5 million adolescents who turned age 11 between 2009 and 2014, had not had a previous Tdap/HPV/MenACWY vaccine, and had at least 1 year of follow-up data.

During a median follow-up of 16 months, 56% of adolescents received at least one vaccination; 18% received HPV, 52% Tdap, and 46% MenACWY. Coadministration occurred in nearly all ado…